BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kythera Biopharmaceuticals 

27200 West Agoura Road
Suite 200
Calabasas  California  91301  U.S.A.
Phone: 818-587-4500 Fax: 818-587-4591


SEARCH JOBS










 Company News
Kythera Biopharmaceuticals (KYTH) Announces 2013 Operating Results 3/18/2014 8:46:20 AM    More...
Kythera Biopharmaceuticals (KYTH) Buys Back Double Chin-Fat Therapy From Bayer Consumer Care In $84 Million Stock, Cash Deal 3/11/2014 7:35:37 AM    More...
Kythera Biopharmaceuticals (KYTH) To Release 2013 Operating Results 3/10/2014 9:14:55 AM    More...
Kythera Biopharmaceuticals (KYTH) To Present At 32nd Annual J.P. Morgan Healthcare Conference 1/7/2014 9:46:15 AM    More...
Kythera Biopharmaceuticals (KYTH) Announces Addition To The NASDAQ Biotechnology Index 12/20/2013 9:57:31 AM    More...
Kythera Biopharmaceuticals (KYTH) Announces Proposed Public Offering of Common Stock 10/8/2013 9:49:05 AM    More...
Kythera Biopharmaceuticals (KYTH) Reports Additional Positive Efficacy and Patient Satisfaction Data From ATX-101 in Phase 3 Trials for the Reduction of Submental Fat 10/7/2013 7:36:26 AM    More...
Kythera Biopharmaceuticals (KYTH) Appoints F. Michael Ball to Board of Directors 9/20/2013 10:00:44 AM    More...
Kythera Biopharmaceuticals (KYTH)' Drug Successfully Reduces Double Chin in Studies 9/18/2013 7:29:01 AM    More...
Kythera Biopharmaceuticals Announces Positive ATX-101 Top Line Phase 3 Trial Results for the Reduction of Submental Fat 9/17/2013 9:30:40 AM    More...
12345678